We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
In this special report, Drug Industry Daily examines how the drug supply chain has evolved during the pandemic. Part 2 focuses on efforts to shore up the supply chain, including the promotion of domestic manufacturing.Read More
Becoming — and remaining — in compliance with FDA regulations is often a result of creating and maintaining a quality culture but measuring the maturity of that culture takes more than just looking at metrics, according to several experts speaking at a recent FDAnews webinar. Read More
Lyne Laboratories’ Brockton, Mass., drug manufacturing facility was handed a seven-observation Form 483 for inadequate investigations of complaints, lax batch records and other deficiencies. Read More
In this special report, Drug Industry Daily examines how the drug supply chain has evolved during the pandemic. Part 1 focuses on the special challenges to manufacturers of generics.Read More